Dimerix (ASX:DXB) has confirmed that the first clinical trial site in Japan is now open for recruitment, triggering the first development milestone payment of ¥400 million (~AU$4.3 million) from FUSO Pharmaceutical Industries, the exclusive licensee of DMX-200 for FSGS in Japan. …
Dimerix says first ACTION3 trial site activated in Japan and first milestone payment triggered
May 30, 2025 Australian Biotech
Latest Video
Georgia Forrest
New Stories
-
It is profoundly wrong for any system to exclude compassion while outsourcing it to others
March 16, 2026 - - Latest News -
Scientists identify highly specific targets that could transform multiple myeloma treatment
March 15, 2026 - - Australian Biotech -
CSL Seqirus' adjuvanted flu vaccine approval extended to Australians aged 50 and over
March 15, 2026 - - Latest News -
GSK claims Pharma Cup as Kosi Challenge surpasses fundraising record
March 15, 2026 - - Latest News -
New program aims to make women’s health care more affordable and accessible
March 13, 2026 - - Latest News -
Australians turn to local pharmacies as frontline of everyday healthcare
March 13, 2026 - - Latest News -
Sandoz and Camp Quality unite to strengthen support for Australian families facing childhood cancer
March 13, 2026 - - Latest News